#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	804	CRP	633	633	99.53	CRP.l15.c4.ctg.1	1214	35.3	0	.	p	.	0	K29T	NONSYN	85	87	AAG	352	354	ACG	31;30;27	A;C;G	31;30;27	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	1	1	528	96	Enterobacter_aerogenes_omp36	1128	92	93.48	Enterobacter_aerogenes_omp36.l15.c4.ctg.6	108	6.0	0	.	p	.	0	L329V	NONSYN	985	987	CTG	9	11	GTT	3;3;3	G;T;T	3;3;3	.	Enterobacter aerogenes omp36 mutants
Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	1	1	528	96	Enterobacter_aerogenes_omp36	1128	92	93.48	Enterobacter_aerogenes_omp36.l15.c4.ctg.6	108	6.0	0	.	p	.	0	K354Q	NONSYN	1060	1062	AAG	84	86	CAG	1;1;1	C;A;G	1;1;1	.	Enterobacter aerogenes omp36 mutants
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	179	2780	Escherichia_coli_EF_Tu	1230	1224	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1506	90.5	1	SNP	p	R234F	1	.	.	700	702	TTC	982	984	TTC	117;117;120	T;T;C	116;115;119	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	179	2780	Escherichia_coli_EF_Tu	1230	1224	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1506	90.5	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1282	1284	CGT	119;123;121	C;G;T	119;123;121	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	179	2780	Escherichia_coli_EF_Tu	1230	1224	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1506	90.5	0	HET	.	.	.	C255T	.	255	255	C	537	537	C	97	C,T	55,42	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1134	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1903	31.5	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1595	1597	AAA	22;20;18	A;A;A	22;20;18	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1548	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l6.c4.ctg.1	1925	42.6	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1288	1290	GAA	61;62;60	G;A;A	61;62;60	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	346	H_NS	414	414	99.03	H_NS.l6.c4.ctg.1	1006	18.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	T1041G	SNP	1041	1041	T	16	16	G	180	G	149	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	A1042T	SNP	1042	1042	A	17	17	T	184	T,G	153,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	A1136G	SNP	1136	1136	A	111	111	G	197	G	195	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	T1138C	SNP	1138	1138	T	113	113	C	187	C	187	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	T1142C	SNP	1142	1142	T	117	117	C	168	C	168	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	C1170T	SNP	1170	1170	C	145	145	T	176	T,C	175,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	T1220C	SNP	1220	1220	T	195	195	C	190	C	189	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	T1245C	SNP	1245	1245	T	220	220	C	149	C	149	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	G1253A	SNP	1253	1253	G	228	228	A	145	A	145	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	G1256A	SNP	1256	1256	G	231	231	A	150	A	149	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	C1258A	SNP	1258	1258	C	233	233	A	148	A	147	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	G1266T	SNP	1266	1266	G	241	241	T	139	T	136	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	T1267C	SNP	1267	1267	T	242	242	C	136	C	136	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	T1275C	SNP	1275	1275	T	250	250	C	123	C	122	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	G1276A	SNP	1276	1276	G	251	251	A	120	A	119	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	A1281G	SNP	1281	1281	A	256	256	G	111	G	111	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	T1283C	SNP	1283	1283	T	258	258	C	115	C	115	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	G1288T	SNP	1288	1288	G	263	263	T	122	T	121	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	A1296G	SNP	1296	1296	A	271	271	G	171	G	170	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	T1299G	SNP	1299	1299	T	274	274	G	184	G	184	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	A1300T	SNP	1300	1300	A	275	275	T	186	T,G	185,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	C1356T	SNP	1356	1356	C	331	331	T	215	T	214	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	A1358G	SNP	1358	1358	A	333	333	G	205	G,T	204,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	T1368C	SNP	1368	1368	T	343	343	C	151	C	151	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	G1370A	SNP	1370	1370	G	345	345	A	140	A	140	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	C1406.	DEL	1406	1406	C	380	380	C	90	C	90	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	.1409C	INS	1409	1409	T	384	384	C	88	C,A	87,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	C1431A	SNP	1431	1431	C	406	406	A	26	A	26	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	C1432A	SNP	1432	1432	C	407	407	A	26	A	26	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	A1441G	SNP	1441	1441	A	416	416	G	25	G	25	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	T1464C	SNP	1464	1464	T	439	439	C	37	C	37	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	G1473T	SNP	1473	1473	G	448	448	T	88	T	88	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	A1475G	SNP	1475	1475	A	450	450	G	100	G	98	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	.	n	.	0	A1548T	SNP	1548	1548	A	523	523	T	87	T	86	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	1	SNP	n	C1194G	0	.	.	1194	1194	C	169	169	C	190	C	189	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.3	534	179.1	0	HET	.	.	.	T1040C	.	1040	1040	T	15	15	T	152	T,C	61,59	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	173	90.17	Pasteurella_multocida_16S.l15.c30.ctg.6	172	60.8	0	.	n	.	0	T50C	SNP	50	50	T	41	41	C	60	C	28	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	173	90.17	Pasteurella_multocida_16S.l15.c30.ctg.6	172	60.8	0	.	n	.	0	G74A	SNP	74	74	G	65	65	A	23	A	23	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	173	90.17	Pasteurella_multocida_16S.l15.c30.ctg.6	172	60.8	0	.	n	.	0	G81.	DEL	81	81	G	71	71	A	23	A	23	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	173	90.17	Pasteurella_multocida_16S.l15.c30.ctg.6	172	60.8	0	.	n	.	0	A83C	SNP	83	83	A	73	73	C	23	C	23	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	173	90.17	Pasteurella_multocida_16S.l15.c30.ctg.6	172	60.8	0	.	n	.	0	T93G	SNP	93	93	T	82	82	G	21	G	21	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	173	90.17	Pasteurella_multocida_16S.l15.c30.ctg.6	172	60.8	0	.	n	.	0	T97C	SNP	97	97	T	86	86	C	21	C	21	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	173	90.17	Pasteurella_multocida_16S.l15.c30.ctg.6	172	60.8	0	.	n	.	0	T128C	SNP	128	128	T	117	117	C	37	C	37	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	173	90.17	Pasteurella_multocida_16S.l15.c30.ctg.6	172	60.8	0	.	n	.	0	T135A	SNP	135	135	T	124	124	A	45	A	45	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	173	90.17	Pasteurella_multocida_16S.l15.c30.ctg.6	172	60.8	0	.	n	.	0	G139C	SNP	139	139	G	128	128	C	55	C	54	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	173	90.17	Pasteurella_multocida_16S.l15.c30.ctg.6	172	60.8	0	.	n	.	0	T142G	SNP	142	142	T	131	131	G	64	G	64	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	173	90.17	Pasteurella_multocida_16S.l15.c30.ctg.6	172	60.8	0	.	n	.	0	G159A	SNP	159	159	G	148	148	A	84	A	84	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	173	90.17	Pasteurella_multocida_16S.l15.c30.ctg.6	172	60.8	0	.	n	.	0	G161T	SNP	161	161	G	150	150	T	84	T	84	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	173	90.17	Pasteurella_multocida_16S.l15.c30.ctg.6	172	60.8	0	.	n	.	0	T168G	SNP	168	168	T	157	157	G	81	G	81	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	672	3798	Pasteurella_multocida_16S	1551	173	90.17	Pasteurella_multocida_16S.l15.c30.ctg.6	172	60.8	0	.	n	.	0	C170T	SNP	170	170	C	159	159	T	78	T	78	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1148	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1582	38.4	0	.	p	.	0	H2R	NONSYN	4	6	CAT	238	240	CGT	32;33;36	C;G;T	31;33;36	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1148	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1582	38.4	0	.	p	.	0	V30I	NONSYN	88	90	GTC	322	324	ATC	50;49;51	A;T;C	50;48;51	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1148	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1582	38.4	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1081	1083	GGC	37;35;33	G;G;C	36;35;33	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1650	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2299	38.3	0	.	p	.	0	R8S	NONSYN	22	24	AGA	314	316	AGC	23;24;24	A;G;C	23;24;23	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1650	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2299	38.3	0	.	p	.	0	I142L	NONSYN	424	426	ATA	716	718	CTA	38;38;37	C;T;A	38;38;37	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1650	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2299	38.3	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1235	1237	CAA	50;50;50	C;A;A	48;50;49	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1650	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2299	38.3	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1334	1336	GGT	47;48;48	G;G;T	47;48;47	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1650	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2299	38.3	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1904	1906	GTT	29;28;28	G;T;T	29;28;28	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	650	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1675	20.6	0	.	p	.	0	A125E	NONSYN	373	375	GCA	654	656	GAA	16;15;14	G;A;A	16;15;14	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	650	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1675	20.6	0	.	p	.	0	M185T	NONSYN	553	555	ATG	834	836	ACC	12;12;12	A;C;C	12;12;12	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	650	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1675	20.6	0	.	p	.	0	S225T	NONSYN	673	675	TCC	954	956	ACT	16;15;15	A;C;T	16;15;15	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	650	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1675	20.6	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1344	1346	ATC	14;15;15	A;T;C	13;15;15	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	870	PmrF	969	969	99.38	PmrF.l6.c30.ctg.1	1500	30.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	528	54	TEM_1+	858	432	98.61	TEM_1+.l15.c30.ctg.1	440	3.4	0	.	p	.	0	F19L	NONSYN	55	57	TTT	63	65	CTT	5;5;5	C;T;T	5;5;5	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	528	54	TEM_1+	858	432	98.61	TEM_1+.l15.c30.ctg.1	440	3.4	0	.	p	.	0	V82I	NONSYN	244	246	GTT	252	254	ATT	1;1;1	A;T;T	1;1;1	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	528	54	TEM_1+	858	432	98.61	TEM_1+.l15.c30.ctg.1	440	3.4	0	.	p	.	0	M127S	NONSYN	379	381	ATG	387	389	TCG	9;9;9	T;C;G	9;9;9	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	27	960	aad-	789	789	100.0	aad-.l15.c30.ctg.1	1408	36.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
acrB.3000216.DQ679966.1515_4662.624	acrB.3000216.DQ679966.1515_4662.624	1	0	16	62	acrB	3147	138	91.3	acrB.l6.c4.ctg.2	139	9.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	acrB;Protein subunit of AcrA-AcrB-TolC multidrug efflux complex. AcrB functions as a herterotrimer which forms the inner membrane component and is primarily responsible for substrate recognition and energy transduction by acting as a drug/proton antiporter.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2748	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3638	40.1	0	.	p	.	0	T85I	NONSYN	253	255	ACC	487	489	ATC	47;47;48	A;T;C	47;47;48	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2748	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3638	40.1	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2200	2202	AAG	47;47;47	A;A;G	47;47;47	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1074	acrE	1158	1158	98.79	acrE.l15.c17.ctg.1	1735	32.8	0	.	p	.	0	A22V	NONSYN	64	66	GCC	316	318	GTC	8;7;10	G;T;C	8;7;10	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1074	acrE	1158	1158	98.79	acrE.l15.c17.ctg.1	1735	32.8	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1057	1059	TGC	56;58;61	T;G;C	56;57;61	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2632	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3172	43.8	0	.	p	.	0	S46trunc	TRUNC	136	136	T	456	456	T	27	T	27	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2632	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3172	43.8	0	.	p	.	0	G148D	NONSYN	442	444	GGC	762	764	GAC	45;44;46	G;A;C	44;44;45	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2632	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3172	43.8	0	.	p	.	0	F240L	NONSYN	718	720	TTT	1038	1040	TTA	32;32;32	T;T;A	32;32;32	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2632	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3172	43.8	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1221	1223	AAT	28;30;30	A;A;T	28;30;28	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2632	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3172	43.8	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	2008	2008	T	41	T	41	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	796	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1224	34.6	1	SNP	p	R45C	0	.	.	133	135	CGC	399	401	CGC	80;79;81	C;G;C	80;79;81	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	590	acrS	663	663	98.64	acrS.l15.c30.ctg.1	1269	24.8	0	.	p	.	0	L34F	NONSYN	100	102	CTC	387	389	TTC	25;25;25	T;T;C	25;25;25	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	590	acrS	663	663	98.64	acrS.l15.c30.ctg.1	1269	24.8	0	.	p	.	0	E122G	NONSYN	364	366	GAG	651	653	GGG	41;41;38	G;G;G	41;41;38	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	916	adiY	762	762	99.61	adiY.l6.c4.ctg.1	1375	35.3	0	.	p	.	0	V136L	NONSYN	406	408	GTT	701	703	CTT	54;52;53	C;T;T	54;52;53	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2760	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3276	45.0	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2153	2155	GCA	74;75;76	G;C;A	74;75;76	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2760	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3276	45.0	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2414	2416	ACC	59;56;57	A;C;C	58;56;57	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2760	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3276	45.0	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2723	2725	GCC	33;32;30	G;C;C	33;31;29	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1346	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2262	31.2	0	.	p	.	0	G37A	NONSYN	109	111	GGT	169	171	GCT	10;10;10	G;C;T	10;10;10	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1346	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2262	31.2	0	.	p	.	0	D77E	NONSYN	229	231	GAT	289	291	GAG	6;5;5	G;A;G	6;5;5	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1346	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2262	31.2	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	325	327	TGC	6;6;7	T;G;C	6;6;7	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1346	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2262	31.2	0	.	p	.	0	I150V	NONSYN	448	450	ATT	508	510	GTT	23;23;25	G;T;T	23;23;25	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1346	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2262	31.2	0	.	p	.	0	R200H	NONSYN	598	600	CGC	658	660	CAC	21;21;22	C;A;C	21;21;22	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1346	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2262	31.2	0	.	p	.	0	T295M	NONSYN	883	885	ACG	943	945	ATG	53;53;52	A;T;G,C	53;51;50,1	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1346	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2262	31.2	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1939	1941	CGC	27;27;26	C;G;C	27;27;26	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	688	bacA	822	822	98.54	bacA.l6.c30.ctg.1	1466	25.0	0	.	p	.	0	S221T	NONSYN	661	663	AGC	999	1001	ACC	13;13;13	A;C;C	13;13;13	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	688	bacA	822	822	98.54	bacA.l6.c30.ctg.1	1466	25.0	0	.	p	.	0	P225S	NONSYN	673	675	CCG	1011	1013	TCG	16;16;16	T;C;G	16;16;16	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	588	baeR	723	723	97.79	baeR.l15.c30.ctg.1	1241	25.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1052	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1717	31.8	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1426	1428	AAA	6;6;6	A;A;A	6;5;6	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1052	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1717	31.8	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1438	1440	GAG	5;5;5	G;A;G	4;4;5	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1052	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1717	31.8	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1444	1446	CAC	8;12;12	C;A;C	7;12;11	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1052	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1717	31.8	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1498	1500	GAG	25;23;23	G;A;G	25;23;23	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1322	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	1965	35.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	798	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1244	34.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	874	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1505	30.7	0	.	p	.	0	A146T	NONSYN	436	438	GCT	688	690	ACT	37;36;37	A;C;T	37;36;36	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
dfrA1.manually_added_NC_007384_WP_000777554.1_4111923_4112396	dfrA1.manually_added_NC_007384_WP_000777554.1_4111923_4112396	1	0	27	558	dfrA1_1	474	474	100.0	dfrA1_1.l15.c30.ctg.1	956	30.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1046	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1842	30.3	0	.	p	.	0	I219V	NONSYN	655	657	ATC	952	954	GTC	38;37;37	G;T;C	36;36;36	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	1618	emrB	1539	1539	99.74	emrB.l15.c4.ctg.1	2063	41.4	0	.	p	.	0	E197K	NONSYN	589	591	GAA	843	845	AAA	54;54;53	A;A;A	54;54;53	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1042	emrD	1191	1191	98.4	emrD.l15.c4.ctg.1	1501	35.6	0	.	p	.	0	G209S	NONSYN	625	627	GGC	873	875	AGC	35;33;29	A;G;C	35;33;29	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	528	36	emrE_1	333	166	90.96	emrE_1.l15.c30.ctg.1	166	2.9	0	.	p	.	0	I100V	NONSYN	298	300	ATT	144	146	GTC	2;2;2	G;T;C	2;2;2	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	850	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1671	27.2	0	.	p	.	0	K176R	NONSYN	526	528	AAG	815	817	AGG	29;29;30	A;G;G	29;28;30	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	850	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1671	27.2	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1205	1207	GAC	24;24;23	G;A;C	24;24;23	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	642	emrR	531	531	100.0	emrR.l15.c30.ctg.1	1105	30.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1500	emrY	1539	1539	99.81	emrY.l6.c4.ctg.1	2166	36.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	578	evgA	615	615	99.19	evgA.l15.c17.ctg.1	1077	28.2	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	378	380	CTG	27;27;26	C;T;G	27;26;26	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2676	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	4139	34.3	0	.	p	.	0	T38I	NONSYN	112	114	ACA	377	379	ATA	19;19;19	A;T;A	19;19;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2676	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	4139	34.3	0	.	p	.	0	L42V	NONSYN	124	126	CTA	389	391	GTA	22;23;23	G;T;A	22;23;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2676	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	4139	34.3	0	.	p	.	0	A93T	NONSYN	277	279	GCG	542	544	ACG	30;28;29	A;C;G	30;28;29	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2676	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	4139	34.3	0	.	p	.	0	A114E	NONSYN	340	342	GCA	605	607	GAA	27;27;27	G;A;A	27;27;27	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2676	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	4139	34.3	0	.	p	.	0	T127A	NONSYN	379	381	ACT	644	646	GCT	29;29;28	G;C;T	29;29;28	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2676	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	4139	34.3	0	.	p	.	0	N133D	NONSYN	397	399	AAT	662	664	GAT	25;25;26	G;A;T	24;25;26	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2676	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	4139	34.3	0	.	p	.	0	P162S	NONSYN	484	486	CCA	749	751	TCA	29;29;27	T;C;A	29;29;27	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2676	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	4139	34.3	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	878	880	CAG	21;23;22	C;A;G	21;23;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2676	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	4139	34.3	0	.	p	.	0	I251V	NONSYN	751	753	ATT	1016	1018	GTT	16;17;16	G;T;T	15;17;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2676	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	4139	34.3	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1172	1174	GAT	16;15;15	G;A;T	16;15;15	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2676	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	4139	34.3	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1340	1342	AAT	21;21;20	A;A;T	21;21;20	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2676	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	4139	34.3	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1361	1363	TTA	9;10;9	T;T;A	9;10;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2676	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	4139	34.3	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1562	1564	AAA	23;23;23	A;A;A	23;23;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2676	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	4139	34.3	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2297	2299	CAT	42;42;43	C;A;T	42;42;43	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2676	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	4139	34.3	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2351	2353	CAT	26;25;23	C;A;T	26;25;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2676	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	4139	34.3	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2369	2371	AGA	25;24;24	A;G;A	25;24;24	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2676	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	4139	34.3	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2384	2386	AAT	26;26;26	A;A;T	26;26;26	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2676	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	4139	34.3	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2531	2533	TCC	22;22;24	T;C;C	22;22;24	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2676	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	4139	34.3	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2696	2698	ATT	26;26;26	A;T;T	26;26;26	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2676	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	4139	34.3	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2717	2719	GAT	23;22;22	G;A;T	23;22;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2676	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	4139	34.3	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2831	2833	GTT	42;41;36	G;T;T	42;41;36	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2676	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	4139	34.3	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3116	3118	CAC	41;41;39	C;A;C	41;41;39	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	794	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1487	28.4	1	SNP	p	P64H	0	.	.	190	192	CCA	498	500	CCA	55;53;55	C;C;A	55;53;53	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	794	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1487	28.4	1	SNP	p	P64S	0	.	.	190	192	CCA	498	500	CCA	55;53;55	C;C;A	55;53;53	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	794	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1487	28.4	1	SNP	p	P64R	0	.	.	190	192	CCA	498	500	CCA	55;53;55	C;C;A	55;53;53	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	794	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1487	28.4	1	SNP	p	P64L	0	.	.	190	192	CCA	498	500	CCA	55;53;55	C;C;A	55;53;53	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	794	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1487	28.4	1	SNP	p	P64A	0	.	.	190	192	CCA	498	500	CCA	55;53;55	C;C;A	55;53;53	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	624	gadE	528	528	100.0	gadE.l15.c4.ctg.1	1195	27.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	186	gadW	729	300	93.0	gadW.l6.c30.ctg.2	300	11.2	0	.	p	.	0	E54D	NONSYN	160	162	GAA	3	5	GAT	7;8;9	G;A;T	6;7;8	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	186	gadW	729	300	93.0	gadW.l6.c30.ctg.2	300	11.2	0	.	p	.	0	I88M	NONSYN	262	264	ATA	105	107	ATG	7;7;7	A;T;G	7;7;7	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	186	gadW	729	300	93.0	gadW.l6.c30.ctg.2	300	11.2	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	108	110	CCG	7;7;6	C;C;G	7;7;6	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	186	gadW	729	300	93.0	gadW.l6.c30.ctg.2	300	11.2	0	.	p	.	0	D100E	NONSYN	298	300	GAC	141	143	GAA	4;4;4	G;A;A	4;4;4	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	186	gadW	729	300	93.0	gadW.l6.c30.ctg.2	300	11.2	0	.	p	.	0	P101S	NONSYN	301	303	CCC	144	146	TCC	4;4;5	T;C;C	4;4;5	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	186	gadW	729	300	93.0	gadW.l6.c30.ctg.2	300	11.2	0	.	p	.	0	R102G	NONSYN	304	306	CGG	147	149	GGG	5;5;5	G;G;G	5;5;5	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	186	gadW	729	300	93.0	gadW.l6.c30.ctg.2	300	11.2	0	.	p	.	0	K110N	NONSYN	328	330	AAA	171	173	AAT	7;7;8	A;A;T	7;7;8	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	628	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1364	24.4	0	.	p	.	0	F53L	NONSYN	157	159	TTC	422	424	TTA	33;33;33	T,G;T;A	31,1;33;33	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	628	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1364	24.4	0	.	p	.	0	V79I	NONSYN	235	237	GTT	500	502	ATT	21;21;20	A;T;T	21;21;20	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	628	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1364	24.4	0	.	p	.	0	R246G	NONSYN	736	738	AGA	1001	1003	GGA	30;31;27	G;G;A	30;31;27	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	628	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1364	24.4	0	.	p	.	0	S248P	NONSYN	742	744	TCG	1007	1009	CCG	29;29;29	C;C;G	29;28;29	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2648	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3258	43.3	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2340	2342	GAA	50;50;51	G;A;A	50;50;51	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2648	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3258	43.3	1	SNP	p	S83I	0	.	.	247	249	TCG	555	557	TCG	44;45;44	T;C;G	42;43;44	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2648	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3258	43.3	1	SNP	p	S83L	0	.	.	247	249	TCG	555	557	TCG	44;45;44	T;C;G	42;43;44	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2648	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3258	43.3	1	SNP	p	S83W	0	.	.	247	249	TCG	555	557	TCG	44;45;44	T;C;G	42;43;44	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2648	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3258	43.3	1	SNP	p	D87N	0	.	.	259	261	GAC	567	569	GAC	47;48;46	G;A;C	44;44;45	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2648	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3258	43.3	1	SNP	p	D87G	0	.	.	259	261	GAC	567	569	GAC	47;48;46	G;A;C	44;44;45	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2648	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3258	43.3	1	SNP	p	D87Y	0	.	.	259	261	GAC	567	569	GAC	47;48;46	G;A;C	44;44;45	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2648	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3258	43.3	1	SNP	p	D87V	0	.	.	259	261	GAC	567	569	GAC	47;48;46	G;A;C	44;44;45	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2648	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3258	43.3	1	SNP	p	D87H	0	.	.	259	261	GAC	567	569	GAC	47;48;46	G;A;C	44;44;45	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2280	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3070	39.3	1	SNP	p	R136G	0	.	.	406	408	CGC	742	744	CGC	40;40;40	C;G;C	39;39;40	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2280	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3070	39.3	1	SNP	p	R136H	0	.	.	406	408	CGC	742	744	CGC	40;40;40	C;G;C	39;39;40	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2280	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3070	39.3	1	SNP	p	R136E	0	.	.	406	408	CGC	742	744	CGC	40;40;40	C;G;C	39;39;40	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2280	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3070	39.3	1	SNP	p	R136I	0	.	.	406	408	CGC	742	744	CGC	40;40;40	C;G;C	39;39;40	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2280	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3070	39.3	1	SNP	p	R136L	0	.	.	406	408	CGC	742	744	CGC	40;40;40	C;G;C	39;39;40	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2280	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3070	39.3	1	SNP	p	R136S	0	.	.	406	408	CGC	742	744	CGC	40;40;40	C;G;C	39;39;40	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2280	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3070	39.3	1	SNP	p	R136C	0	.	.	406	408	CGC	742	744	CGC	40;40;40	C;G;C	39;39;40	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	466	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1260	19.7	0	.	p	.	0	A72P	NONSYN	214	216	GCG	574	576	CCG	20;20;21	C;C;G	20;20;21	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	466	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1260	19.7	0	.	p	.	0	T123A	NONSYN	367	369	ACC	727	729	GCC	24;23;23	G;C;C	23;23;22	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	962	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1530	33.7	0	.	p	.	0	P9S	NONSYN	25	27	CCA	276	278	TCA	28;28;27	T;C;A	28;27;26	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	350	marA	384	384	99.74	marA.l15.c4.ctg.1	949	19.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l15.c4.ctg.1	770	14.1	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	522	524	AGC	19;18;16	A;G;C,T	19;18;15,1	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l15.c4.ctg.1	770	14.1	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	624	626	CAT	10;10;10	C;A;T	7;5;10	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l15.c4.ctg.1	770	14.1	1	SNP	p	V45E	0	.	.	133	135	GTG	348	350	GTG	30;30;33	G;T;G	29;30;33	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l15.c4.ctg.1	770	14.1	1	SNP	p	I49S	0	.	.	145	147	ATC	360	362	ATC	32;32;32	A;T;C	32;31;32	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l15.c4.ctg.1	770	14.1	1	SNP	p	A70T	0	.	.	208	210	GCA	423	425	GCA	17;17;17	G,T;C;A	16,1;17;17	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l15.c4.ctg.1	770	14.1	1	SNP	p	R73S	0	.	.	217	219	CGT	432	434	CGT	19;19;19	C;G;T	19;19;19	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l15.c4.ctg.1	770	14.1	1	SNP	p	R73C	0	.	.	217	219	CGT	432	434	CGT	19;19;19	C;G;T	19;19;19	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l15.c4.ctg.1	770	14.1	1	SNP	p	R77L	0	.	.	229	231	CGC	444	446	CGC	21;21;21	C;G;C	21;21;21	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l15.c4.ctg.1	770	14.1	1	SNP	p	R77C	0	.	.	229	231	CGC	444	446	CGC	21;21;21	C;G;C	21;21;21	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l15.c4.ctg.1	770	14.1	1	SNP	p	L78M	0	.	.	232	234	CTG	447	449	CTG	21;21;21	C;T;G	21;20;21	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l15.c4.ctg.1	770	14.1	1	SNP	p	R94H	0	.	.	280	282	CGC	495	497	CGC	18;17;17	C;G;C	18;17;17	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l15.c4.ctg.1	770	14.1	1	SNP	p	R94S	0	.	.	280	282	CGC	495	497	CGC	18;17;17	C;G;C	18;17;17	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l15.c4.ctg.1	770	14.1	1	SNP	p	V96E	0	.	.	286	288	GTA	501	503	GTA	16;18;19	G;T;A	16;18;19	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	776	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1531	26.5	0	.	p	.	0	S7F	NONSYN	19	21	TCC	64	66	TTC	5;5;5	T;T;C	5;5;5	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	776	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1531	26.5	0	.	p	.	0	R36I	NONSYN	106	108	AGG	151	153	ATC	19;19;19	A;T;C	19;19;19	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	776	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1531	26.5	0	.	p	.	0	E42A	NONSYN	124	126	GAA	169	171	GCC	7;7;7	G;C;C	7;7;7	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	776	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1531	26.5	0	.	p	.	0	N43V	NONSYN	127	129	AAT	172	174	GTG	6;6;6	G;T;G	6;6;6	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	776	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1531	26.5	0	.	p	.	0	E52D	NONSYN	154	156	GAG	199	201	GAT	14;15;16	G;A;T	14;14;16	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	776	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1531	26.5	0	.	p	.	0	N59T	NONSYN	175	177	AAC	220	222	ACC	16;16;16	A;C;C,T	16;16;15,1	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	776	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1531	26.5	0	.	p	.	0	I68L	NONSYN	202	204	ATA	247	249	TTA	15;17;17	T;T;A	15;17;17	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	776	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1531	26.5	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	388	390	CAG	43;44;46	C;A;G	43;44;46	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	776	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1531	26.5	0	.	p	.	0	D128A	NONSYN	382	384	GAC	427	429	GCC	30;31;32	G;C;C	30;31;30	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	776	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1531	26.5	0	.	p	.	0	S163A	NONSYN	487	489	TCG	532	534	GCG	28;29;30	G,T;C;G	26,1;28;29	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	776	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1531	26.5	0	.	p	.	0	L231V	NONSYN	691	693	CTT	736	738	GTT	20;20;22	G;T;T	17;18;20	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	776	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1531	26.5	0	.	p	.	0	R285fs	FSHIFT	853	853	C	898	898	C	24	C	24	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	670	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1788	19.9	0	.	p	.	0	V12trunc	TRUNC	34	34	G	287	287	G	22	G	22	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	670	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1788	19.9	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	344	346	CAG	11;13;13	C;A;G	11;13;13	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	670	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1788	19.9	0	.	p	.	0	T83I	NONSYN	247	249	ACC	494	496	ATC	18;17;16	A;T;C	18;17;15	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	670	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1788	19.9	0	.	p	.	0	I99M	NONSYN	295	297	ATA	542	544	ATG	14;15;15	A;T;G	14;15;15	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	670	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1788	19.9	0	.	p	.	0	A130T	NONSYN	388	390	GCC	635	637	ACC	24;24;21	A;C;C	24;24;21	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	670	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1788	19.9	0	.	p	.	0	P257T	NONSYN	769	771	CCG	1016	1018	ACG	17;16;15	A;C;G	17;16;15	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2658	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3472	40.5	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1998	2000	ACC	56;56;55	A;C;C	56;56;55	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2658	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3472	40.5	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2391	2393	CAA	36;36;38	C;A;A	35;36;37	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2658	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3472	40.5	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2559	2561	ATT	34;35;36	A;T;T	34;35;36	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2658	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3472	40.5	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2643	2645	GTT	41;42;41	G;T;T,C	41;41;40,1	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2658	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3472	40.5	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2751	2753	GAG	34;31;32	G;A;G	34;31;32	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2658	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3472	40.5	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2979	2981	ATG	30;31;31	A;T;G	30;31;31	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2658	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3472	40.5	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3114	3116	GAT	32;31;32	G;A;T	32;30;32	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2448	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3310	38.7	0	.	p	.	0	I46M	NONSYN	136	138	ATC	346	348	ATG	28;28;28	A;T;G	28;28;28	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2448	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3310	38.7	0	.	p	.	0	V208I	NONSYN	622	624	GTC	832	834	ATC	53;54;52	A;T;C	53;54;52	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2448	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3310	38.7	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3148	3150	CAC	8;7;7	C;A;C	8;7;7	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2448	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3310	38.7	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3151	3153	CTC	7;7;7	C;T;C	7;7;7	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1158	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	2067	29.7	0	.	p	.	0	D3E	NONSYN	7	9	GAT	298	300	GAA	14;13;13	G;A;A	13;13;13	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1158	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	2067	29.7	0	.	p	.	0	T226A	NONSYN	676	678	ACG	967	969	GCG	34;35;34	G;C,G;G	34;33,1;34	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1158	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	2067	29.7	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1309	1311	ATC	32;33;34	A;T;C	31;31;33	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1158	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	2067	29.7	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1612	1614	TTT	43;45;45	T;T;T	43;45;45	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1258	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1772	37.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3046	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3687	44.0	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1177	1179	ACC	29;29;30	A;C,A;C	29;22,3;29	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3046	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3687	44.0	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2419	2421	GAC	49;47;48	G;A;C	49;47;47	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1118	mdtG	1227	1047	99.33	mdtG.l15.c17.ctg.1	1594	31.4	0	.	p	.	0	V200I	NONSYN	598	600	GTC	675	677	ATC	50;52;52	A;T;C	50;52;52	.	Efflux protien mdtG.;mdtG
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1118	mdtG	1227	177	99.44	mdtG.l15.c17.ctg.2	413	15.6	0	.	p	.	0	E5G	NONSYN	13	15	GAA	8	10	GGA	3;3;3	G;G;A	3;3;3	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	876	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1762	26.5	0	.	p	.	0	G134C	NONSYN	400	402	GGT	695	697	TGT	31;29;30	T;G;T	30;29;30	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	876	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1762	26.5	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1265	1267	TTG	42;38;37	T;T;G	41;38;37	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	876	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1762	26.5	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1475	1477	ACG	21;21;21	A;C;G	20;21;21	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1242	mdtL	1176	1176	98.38	mdtL.l15.c4.ctg.1	1717	38.4	0	.	p	.	0	A185S	NONSYN	553	555	GCC	767	769	TCC	32;32;33	T;C;C	32;32;33	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	810	mdtN	1032	1032	98.06	mdtN.l15.c4.ctg.1	1574	27.4	0	.	p	.	0	V119I	NONSYN	355	357	GTT	620	622	ATT	25;26;27	A;T;T	24;26;27	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1782	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2529	37.4	0	.	p	.	0	V11M	NONSYN	31	33	GTG	204	206	ATG	30;29;30	A;T;G	30;29;30	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1782	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2529	37.4	0	.	p	.	0	T33I	NONSYN	97	99	ACC	270	272	ATC	18;19;21	A;T;C	18;18;21	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1782	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2529	37.4	0	.	p	.	0	C116R	NONSYN	346	348	TGC	519	521	CGC	48;49;50	C;G;C,T	44;48;47,1	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1782	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2529	37.4	0	.	p	.	0	N238S	NONSYN	712	714	AAC	885	887	AGC	39;40;40	A;G;C	39;38;40	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1782	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2529	37.4	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1086	1088	GTG	27;29;29	G;T;G,T	27;25;28,1	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1782	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2529	37.4	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1149	1151	AAC	21;21;21	A;A;C	21;21;20	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1782	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2529	37.4	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1194	1196	GTC	44;44;45	G;T;C	43;44;45	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1782	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2529	37.4	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1224	1226	ATA	65;64;65	A,G;T;A	64,1;63;65	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1782	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2529	37.4	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1332	1334	TCT	38;38;39	T;C;T	38;38;39	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1782	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2529	37.4	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1719	1721	GCG	37;40;41	G;C;G	36;40;41	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1782	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2529	37.4	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1932	1934	ATC	43;44;44	A;T;C	43;42;43	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1122	mdtP	1467	1467	97.96	mdtP.l15.c17.ctg.1	2028	29.3	0	.	p	.	0	S129A	NONSYN	385	387	TCA	723	725	GCG	33;32;33	G;C;G	32;32;33	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1122	mdtP	1467	1467	97.96	mdtP.l15.c17.ctg.1	2028	29.3	0	.	p	.	0	A187T	NONSYN	559	561	GCC	897	899	ACC	32;32;33	A;C;C	32;32;33	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1122	mdtP	1467	1467	97.96	mdtP.l15.c17.ctg.1	2028	29.3	0	.	p	.	0	H211R	NONSYN	631	633	CAC	969	971	CGC	41;39;39	C;G;C	41;38;39	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1122	mdtP	1467	1467	97.96	mdtP.l15.c17.ctg.1	2028	29.3	0	.	p	.	0	V250A	NONSYN	748	750	GTT	1086	1088	GCT	29;30;31	G;C;T	29;30;31	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1122	mdtP	1467	1467	97.96	mdtP.l15.c17.ctg.1	2028	29.3	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1170	1172	AAA	22;22;22	A;A;A	21;22;22	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1122	mdtP	1467	1467	97.96	mdtP.l15.c17.ctg.1	2028	29.3	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1188	1190	CGA	29;30;33	C;G;A	29;29;32	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1122	mdtP	1467	1467	97.96	mdtP.l15.c17.ctg.1	2028	29.3	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1353	1355	GCC	32;31;31	G;C;C	32;31;31	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1122	mdtP	1467	1467	97.96	mdtP.l15.c17.ctg.1	2028	29.3	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1365	1367	GAT	32;32;33	G;A;T	32;32;33	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1122	mdtP	1467	1467	97.96	mdtP.l15.c17.ctg.1	2028	29.3	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1782	1784	GCT	15;14;14	G;C;T	13;13;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2748	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3948	37.1	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1577	1579	AAG	25;26;23	A;A;G	24;25;21	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2748	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3948	37.1	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2654	2656	CTG	43;42;41	C;T;G	43;42;41	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	188	mgrB	144	144	100.0	mgrB.l15.c30.ctg.2	185	27.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1694	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2321	38.9	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1053	1055	AAC	31;31;32	A;A;C	31;31;32	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1694	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2321	38.9	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1599	1601	ATA	36;37;38	A;T;A	34;36;37	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1374	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1749	41.8	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1348	1350	GAT	55;55;56	G;A;T	55;54;55	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1374	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1749	41.8	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1351	1353	CTG	57;58;57	C;T;G	57;58;57	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	590	nfsA	723	723	98.89	nfsA.l15.c4.ctg.1	1331	23.6	0	.	p	.	0	R27C	NONSYN	79	81	CGT	381	383	TGT	26;26;26	T;G;T	26;26;26	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	590	nfsA	723	723	98.89	nfsA.l15.c4.ctg.1	1331	23.6	0	.	p	.	0	I117T	NONSYN	349	351	ATC	651	653	ACC	40;39;39	A;C;C	40;39;39	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	590	nfsA	723	723	98.89	nfsA.l15.c4.ctg.1	1331	23.6	0	.	p	.	0	G187D	NONSYN	559	561	GGC	861	863	GAC	31;30;30	G;A;C	31;30;30	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	590	nfsA	723	723	98.89	nfsA.l15.c4.ctg.1	1331	23.6	0	.	p	.	0	R208L	NONSYN	622	624	CGC	924	926	CTC	25;25;25	C;T,G;C	24;21,1;25	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	590	nfsA	723	723	98.89	nfsA.l15.c4.ctg.1	1331	23.6	1	SNP	p	R15C	0	.	.	43	45	CGC	345	347	CGC	46;45;43	C;G;C	46;45;43	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	590	nfsA	723	723	98.89	nfsA.l15.c4.ctg.1	1331	23.6	1	SNP	p	S33R	0	.	.	97	99	AGC	399	401	AGC	28;30;30	A;G;C	27;30;30	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	590	nfsA	723	723	98.89	nfsA.l15.c4.ctg.1	1331	23.6	1	SNP	p	G131D	0	.	.	391	393	GGC	693	695	GGC	39;40;39	G;G;C	38;39;34	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	590	nfsA	723	723	98.89	nfsA.l15.c4.ctg.1	1331	23.6	1	SNP	p	R203L	0	.	.	607	609	CGT	909	911	CGT	29;29;30	C;G;T	29;29;29	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	590	nfsA	723	723	98.89	nfsA.l15.c4.ctg.1	1331	23.6	1	SNP	p	R203C	0	.	.	607	609	CGT	909	911	CGT	29;29;30	C;G;T	29;29;29	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1258	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1668	40.3	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1201	1203	GAG	55;55;55	G;A;G	55;55;55	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1258	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1668	40.3	1	SNP	p	G141E	0	.	.	421	423	GGT	688	690	GGT	58;56;56	G;G;T	57;56;56	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1258	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1668	40.3	1	SNP	p	G141D	0	.	.	421	423	GGT	688	690	GGT	58;56;56	G;G;T	57;56;56	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1258	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1668	40.3	1	SNP	p	R154A	0	.	.	460	462	CGT	727	729	CGT	69;71;71	C;G;T	68;71;71	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1258	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1668	40.3	1	SNP	p	R154D	0	.	.	460	462	CGT	727	729	CGT	69;71;71	C;G;T	68;71;71	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2246	parC_2	2259	2259	99.16	parC_2.l15.c4.ctg.1	2763	43.2	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1932	1934	GTG	54;55;55	G;T;G	53;54;55	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2246	parC_2	2259	2259	99.16	parC_2.l15.c4.ctg.1	2763	43.2	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1959	1961	TCG	55;55;55	T,A;C;G	45,1;50;51	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2246	parC_2	2259	2259	99.16	parC_2.l15.c4.ctg.1	2763	43.2	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2574	2576	AAC	26;27;28	A;A;C	26;27;27	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2246	parC_2	2259	2259	99.16	parC_2.l15.c4.ctg.1	2763	43.2	1	SNP	p	A85T	0	.	.	253	255	GCG	588	590	GCG	52;53;52	G;C;G	50;50;51	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2246	parC_2	2259	2259	99.16	parC_2.l15.c4.ctg.1	2763	43.2	1	SNP	p	D111H	0	.	.	331	333	GAT	666	668	GAT	45;45;45	G;A;T	45;45;45	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2246	parC_2	2259	2259	99.16	parC_2.l15.c4.ctg.1	2763	43.2	1	SNP	p	S129P	0	.	.	385	387	TCC	720	722	TCC	41;42;43	T;C;C	39;42;43	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1464	parE_1	1893	1893	97.52	parE_1.l15.c4.ctg.1	2521	31.0	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1722	1724	AAC	43;47;48	A;A;C	43;47;48	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1464	parE_1	1893	1893	97.52	parE_1.l15.c4.ctg.1	2521	31.0	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1731	1733	GAT	48;48;48	G;A;T	48;48;48	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	527	1550	patA	1380	1380	99.78	patA.l6.c30.ctg.1	2046	40.3	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	960	962	CAG	37;37;38	C;A;G	37;37;38	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	527	1550	patA	1380	1380	99.78	patA.l6.c30.ctg.1	2046	40.3	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1434	1436	GAT	44;45;45	G;A;T	44;45;45	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	527	1550	patA	1380	98	96.94	patA.l6.c30.ctg.2	146	0.4	0	.	p	.	0	I347L	NONSYN	1039	1041	ATC	34	36	CTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	527	1550	patA	1380	98	96.94	patA.l6.c30.ctg.2	146	0.4	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	73	75	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	527	1550	patA	1380	98	96.94	patA.l6.c30.ctg.2	146	0.4	0	.	p	.	0	G363C	NONSYN	1087	1089	GGC	82	84	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4632	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4684	52.5	1	SNP	p	V146F	0	.	.	436	438	GTT	751	753	GTT	62;61;59	G;T;T	62;61;59	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4632	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4684	52.5	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1852	1854	CAG	48;49;51	C;A;G	48;49;51	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4632	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4684	52.5	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1852	1854	CAG	48;49;51	C;A;G	48;49;51	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4632	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4684	52.5	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1891	1893	CAC	53;54;55	C;A;C	53;54;55	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4632	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4684	52.5	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1900	1902	CGT	49;48;47	C;G;T	49;47;46	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4632	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4684	52.5	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1900	1902	CGT	49;48;47	C;G;T	49;47;46	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4632	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4684	52.5	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1906	1908	TCC	48;48;47	T;C;C,G	47;47;46,1	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4632	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4684	52.5	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1912	1914	CTC	43;44;44	C;T;C	43;44;44	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4632	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4684	52.5	1	SNP	p	T563P	0	.	.	1687	1689	ACC	2002	2004	ACC	54;55;55	A;C;C	54;55;55	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4632	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4684	52.5	1	SNP	p	P564L	0	.	.	1690	1692	CCT	2005	2007	CCT	52;55;55	C;C;T	52;55;55	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4632	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4684	52.5	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2374	2376	CGT	83;83;81	C,G;G;T	82,1;82;80	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11540	rrsB+	1542	143	100.0	rrsB+.l15.c30.ctg.1	143	83.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11540	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1071	321.0	0	.	n	.	0	A226G	SNP	226	226	A	296	296	G	370	G	368	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11540	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1071	321.0	1	SNP	n	A794G	0	.	.	794	794	A	864	864	A	345	A	339	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11540	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1071	321.0	1	SNP	n	A794T	0	.	.	794	794	A	864	864	A	345	A	339	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11540	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1071	321.0	1	SNP	n	G926A	0	.	.	926	926	G	996	996	G	321	G	320	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11540	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1071	321.0	1	SNP	n	G926T	0	.	.	926	926	G	996	996	G	321	G	320	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11540	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1071	321.0	1	SNP	n	G926C	0	.	.	926	926	G	996	996	G	321	G	320	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11540	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1071	321.0	0	HET	.	.	.	T90C	.	90	90	T	160	160	T	323	T,C	244,76	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11540	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1071	321.0	0	HET	.	.	.	A253T	.	253	253	A	323	323	A	318	A,T	257,59	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11540	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1071	321.0	0	HET	.	.	.	C194T	.	194	194	C	264	264	C	311	C,T	263,47	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11540	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1071	321.0	0	HET	.	.	.	G474A	.	474	474	G	544	544	G	350	G,A	282,67	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11540	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1071	321.0	0	HET	.	.	.	A79G	.	79	79	A	149	149	A	311	A,G	223,80	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11540	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1071	321.0	0	HET	.	.	.	C719T	.	719	719	C	789	789	C	292	C,T	171,120	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11540	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1071	321.0	0	HET	.	.	.	T273A	.	273	273	T	343	343	T	306	T,A	242,59	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11540	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1071	321.0	0	HET	.	.	.	C183T	.	183	183	C	253	253	C	314	C,T	227,87	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11540	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1071	321.0	0	HET	.	.	.	A250T,C	.	250	250	A	320	320	A	324	A,T,C	261,59,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11540	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.3	518	364.4	1	SNP	n	A1519C	0	.	.	1519	1519	A	481	481	A	255	A	253	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11540	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.3	518	364.4	1	SNP	n	A1519G	0	.	.	1519	1519	A	481	481	A	255	A	253	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11540	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.3	518	364.4	1	SNP	n	A1519T	0	.	.	1519	1519	A	481	481	A	255	A	253	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11540	rrsB+	1542	138	94.96	rrsB+.l15.c30.ctg.4	138	66.0	0	.	n	.	0	G1002A	SNP	1002	1002	G	50	50	A	121	A	120	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11540	rrsB+	1542	138	94.96	rrsB+.l15.c30.ctg.4	138	66.0	0	.	n	.	0	G1006C	SNP	1006	1006	G	54	54	C	132	C	131	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11540	rrsB+	1542	138	94.96	rrsB+.l15.c30.ctg.4	138	66.0	0	.	n	.	0	T1010C	SNP	1010	1010	T	58	58	C	134	C	132	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11540	rrsB+	1542	138	94.96	rrsB+.l15.c30.ctg.4	138	66.0	0	.	n	.	0	A1019.	DEL	1019	1019	A	66	66	G	129	G	128	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11540	rrsB+	1542	138	94.96	rrsB+.l15.c30.ctg.4	138	66.0	0	.	n	.	0	.1023G	INS	1023	1023	T	71	71	G	128	G	127	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11540	rrsB+	1542	138	94.96	rrsB+.l15.c30.ctg.4	138	66.0	0	.	n	.	0	C1038T	SNP	1038	1038	C	86	86	T	111	T	106	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	722	sat_1	525	525	100.0	sat_1.l15.c4.ctg.1	1086	35.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli;sat-1
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	592	soxR	465	465	100.0	soxR.l15.c4.ctg.2	908	34.4	1	SNP	p	R20H	0	.	.	58	60	CGC	246	248	CGC	50;52;54	C;G;C	50;51;54	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	592	soxR	465	465	100.0	soxR.l15.c4.ctg.2	908	34.4	1	SNP	p	G121D	0	.	.	361	363	GGT	549	551	GGT	56;55;55	G;G;T	56;55;55	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	454	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	970	25.0	1	SNP	p	A12S	0	.	.	34	36	GCA	341	343	GCA	43;45;46	G;C;A	42;45;46	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	27	1946	APH_3____Ib+	804	804	100.0	APH_3____Ib+.l15.c4.ctg.1	1446	71.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	27	1864	APH_6__Id+	837	837	100.0	APH_6__Id+.l15.c4.ctg.1	1383	71.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	1	0	27	1458	sul2	816	816	100.0	sul2.l6.c30.ctg.1	1504	51.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	27	2050	tetA	1200	1200	100.0	tetA.l15.c4.ctg.1	1886	57.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	27	1296	tetR	651	651	100.0	tetR.l15.c4.ctg.1	1287	53.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1658	tolC	1488	1488	98.72	tolC.l15.c30.ctg.1	2169	40.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
